Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 2

Status

Unknown 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Disease 2Stomach Neoplasms 1Gastritis, Atrophic 1

Interventions

Magnetic Resonance Spectroscopy 6Dexamethasone 6Cyclophosphamide 6Blood Specimen Collection 6Prednisone 5Positron Emission Tomography Computed Tomography 4Mammography 4Lenalidomide 4Colonoscopy 4pembrolizumab 3Tomography, X-Ray Computed 3Surveys and Questionnaires 3Melphalan 3Exercise 3Biopsy 32-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 3weifuchun 2obinutuzumab 2fluciclovine F-18 2daratumumab 2carfilzomib 2Preoperative Exercise 2Positron-Emission Tomography 2Methods 2Magnetic Resonance Imaging 2Injections 2Gemcitabine 2Educational Status 2Doxorubicin 2Cytarabine 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Disease × weifuchun × Clear all
NCT05888675 2023-07-25

Clinical Study of Weifuchun Treatment on Gastric Cancer

ShuGuang Hospital

Phase EARLY_PHASE1 Completed
72 enrolled
Gastrointestinal

Disease, Stomach Neoplasms

NCT03814629 2019-01-24

Clinical Study of Weifuchun Treatment on Precancerous Lesions of Gastric Cancer

ShuGuang Hospital

Phase EARLY_PHASE1 Unknown
120 enrolled

Disease, Gastritis, Atrophic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡